These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4823985)

  • 1. Delta9-tetrahydrocannabinol: subcortical spike bursts and motor manifestations in a Fischer rat treated orally for 109 days.
    Stadnicki SW; Schaeppi U; Rosenkrantz H; Braude MC
    Life Sci; 1974 Feb; 14(3):463-72. PubMed ID: 4823985
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of orally administered delta-9-tetrahydrocannabinol in man.
    Hosko MJ; Kochar MS; Wang RI
    Clin Pharmacol Ther; 1973; 14(3):344-52. PubMed ID: 4698562
    [No Abstract]   [Full Text] [Related]  

  • 4. Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns.
    Pivik RT; Zarcone V; Dement WC; Hollister LE
    Clin Pharmacol Ther; 1972; 13(3):426-35. PubMed ID: 4337346
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral delta9-tetrahydrocannabinol toxicity in rats treated for periods up to six months.
    Rosendrantz H; Sprague RA; Fleischman RW; Braude C
    Toxicol Appl Pharmacol; 1975 May; 32(2):399-417. PubMed ID: 1171539
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of oral delta9-tetrahydrocannabinol on operant reinforcement schedule performance in rats.
    Ferraro DP; Gluck JP
    Pharmacology; 1974; 11(2):65-9. PubMed ID: 4829291
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of acute and chronic administration of marijuana extract on the rat electrocorticogram.
    Pirch JH; Cohn RA; Barnes PR; Barratt ES
    Neuropharmacology; 1972 Mar; 11(2):231-40. PubMed ID: 5025827
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of delta-9-tetrahydrocannabinol administration on the lipid constituents of rat brain subcellular fractions.
    Sarkar C; Ghosh JJ
    J Neurochem; 1975 Feb; 24(2):381-5. PubMed ID: 1113115
    [No Abstract]   [Full Text] [Related]  

  • 9. Delta 9-tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits.
    Fujimori M; Himwich HE
    Physiol Behav; 1973 Sep; 11(3):291-5. PubMed ID: 4355439
    [No Abstract]   [Full Text] [Related]  

  • 10. Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of delta9-tetrahydrocannabinol.
    Johnson DD; McNeill JR; Crawford RD; Wilcox WC
    Can J Physiol Pharmacol; 1975 Dec; 53(6):1007-13. PubMed ID: 1222370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine effects of chronic intraventricular administration of delta9-tetrahydrocannabinol to prepuberal and adult male rats.
    Collu R
    Life Sci; 1976 Jan; 18(2):223-30. PubMed ID: 1256238
    [No Abstract]   [Full Text] [Related]  

  • 12. Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat.
    Moreton JE; Davis WM
    Neuropharmacology; 1973 Sep; 12(9):897-907. PubMed ID: 4355678
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of acute and chronic pretreatment with delta1-tetrahydrocannabinol on motor impairment by ethanol in the rat.
    Kalant H; LeBlanc AE
    Can J Physiol Pharmacol; 1974 Apr; 52(2):291-7. PubMed ID: 4838189
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetrahydrocannabinol, sesame oil and biogenic amines: a preliminary report.
    Anton AH; Serrano A; Beyer RD; Lavappa KS
    Life Sci; 1974 May; 14(9):1741-6. PubMed ID: 4407739
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns.
    Feinberg I; Jones R; Walker J; Cavness C; Floyd T
    Clin Pharmacol Ther; 1976 Jun; 19(6):782-94. PubMed ID: 178475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil.
    Ten Ham M; Loskota WJ; Lomax P
    Eur J Pharmacol; 1975 Mar; 31(1):148-52. PubMed ID: 1126373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delta-9-tetrahydrocannabinol on gangliosides and sialoglycoproteins in subcellular fractions of rat brain.
    Sarkar C; Ghosh JJ
    J Neurochem; 1976 Apr; 26(4):721-3. PubMed ID: 965964
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute antiepileptic effects of 9-tetrahydrocannabinol in rats with kindled seizures.
    Corcoran ME; McCaughran JA; Wada JA
    Exp Neurol; 1973 Aug; 40(2):471-83. PubMed ID: 4354188
    [No Abstract]   [Full Text] [Related]  

  • 19. Delta-9-tetrahydrocannabinol, EEG and behavior:the importance of adaptation to the testing milieu.
    Constoe PF; Jones BC; Chin L
    Pharmacol Biochem Behav; 1975; 3(2):173-7. PubMed ID: 1144477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic effects of delta9-tetrahydrocannabinol on food intake by rats.
    Sofia RD; Barry H
    Psychopharmacologia; 1974; 39(3):213-22. PubMed ID: 4427988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.